Eight Roads Ventures — 2019 Investments
4 investments dated 2019 · listed companies and verified rows first · show all
Insilico Medicine uses artificial intelligence to discover and develop new drugs, operating an AI-driven platform for pharmaceutical research and development.
AI & Machine LearningBiotechDigital HealthHealthtechHong Kong, US
Aleksandrs Zavoronkovs(Executive Officer, Director)Alex Zavoronkov(Director)Alex Zhavoronkov(Founder)inAlex Aliper(President)inFeng Ren(Chief Scientific Officer, Executive Director & Co-CEO)in
BoardNisa Leung(Director)in
Co-investorsLilly Asia VenturesOrbiMedQiming Venture PartnersWarburg PincusBaidu VenturesLake Bleu Capital+13 more
ScyllaDB is a NoSQL database built for data-intensive applications requiring high throughput and predictable low latency, powering real-time AI systems at billion-scale data volumes.
AI & Machine LearningData & InfrastructureDeveloper ToolsSaaSNew York, US
Avi Kivity(Founder)inDor Laor(Founder)in
Co-investorsBessemer Venture PartnersMagma Venture PartnersQualcomm VenturesTLV PartnersInnovation EndeavorsVertex Ventures+5 more
InsightFinder AI uses patented unsupervised machine learning for AI Observability and IT Observability, providing real-time anomaly detection, root cause analysis, and incident prediction across logs, metrics, and traces.
AI & Machine LearningCloud ComputingDeveloper ToolsEnterprise SoftwareBrooklyn, US
Xiaohui Gu(Executive Officer, Director, Promoter)Helen Gu(Founder)in
Co-investorsEastlink Capital PartnersFellowsIDEA Fund PartnersYu Galaxy
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

















